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ABSTRACT 
Background 
While educational inequalities in mortality are substantial in most European countries, they are 
relatively small in Spain. A better understanding of the causes of these smaller inequalities in Spain 
may help to develop policies to reduce inequalities in mortality elsewhere. The aim of the present 
study was therefore to identify the specific causes of death and determinants contributing to these 
smaller inequalities.   
Methods 
Data on mortality by education were obtained from longitudinal mortality studies in three Spanish 
populations (Barcelona, Madrid, the Basque Country), and six other Western European populations. 
Data on determinants by education were obtained from health interview surveys. 
Results 
The Spanish populations have considerably smaller absolute inequalities in mortality than other 
Western European populations. This is due mainly to smaller inequalities in mortality from 
cardiovascular disease (men) and cancer (women). Inequalities in mortality from most other causes are 
not smaller in Spain than elsewhere. Spain also has smaller inequalities in smoking and sedentary 
lifestyle and this is due to more smoking and physical inactivity in higher educated groups. 
Conclusion 
Overall, the situation with regard to health inequalities does not appear to be more favourable in Spain 
than in other Western European populations. Smaller inequalities in mortality from cardiovascular 
disease and cancer in Spain are likely to be related to its later socio-economic modernization. 
Although these smaller inequalities in mortality seem to be a historical coincidence rather than the 
outcome of deliberate policies, the Spanish example does suggest that large inequalities in total 
mortality are not inevitable. 
   
Keywords: education, mortality, social inequalities, health behaviour 
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INTRODUCTION 
Mortality differentials among different socio-economic groups belong to the most consistent findings 
in public health, but the magnitude of these inequalities differs substantially between countries. A 
recent study of inequalities in health in 22 European countries in the 1990s showed that some southern 
European populations have relatively small educational inequalities in mortality (1). Smaller 
inequalities in mortality in Spain and Italy were also found in a previous study (2), but have never 
been satisfactorily explained. We therefore conducted an in-depth study of potential explanations for 
smaller inequalities in mortality in Spain.  
Spain is a young democracy, with an underdeveloped welfare state, important income inequalities, 
and a universal national health service (3). Evidence on socio-economic differentials in mortality 
based on individual data is relatively scarce, due to the poor quality of socio-economic information 
included in death certificates, and to restrictive legislation with regard to linkage of the death register 
with census information (4, 5). International literature focused mainly on the city of Barcelona or the 
region of Madrid (5-9). One factor standing out from the more detailed analyses that have been 
performed is smoking: inequalities in smoking are smaller in Spain and Italy than in other Western 
European countries, particularly among women, and this is likely to contribute to smaller inequalities 
in ischemic heart disease (10, 11) and lung cancer (12). Studies which tried to explain the 
comparatively small inequalities in mortality in Spain are non-existent, and a comprehensive 
explanation is lacking so far. 
The present study was based on evidence from three Spanish populations (the city of Barcelona, the 
region of Madrid, and the Basque Country), which were compared with six other Western European 
populations [Finland, Sweden, Norway, Denmark, Belgium, and Turin (Italy)]. Our analysis aimed at 
identifying the specific causes of death and some of the specific determinants which contributed to 
smaller inequalities in total mortality in the three Spanish populations.  
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METHODS 
Study population  
Mortality data were obtained from longitudinal mortality studies based on linkage of death registries to 
population censuses  and consisted of deaths and exposure counts by sex, 5-year age groups, cause of 
death and level of education (table 1). The data covered national (Finland, Sweden, Norway, Denmark, 
Belgium), regional (Madrid, the Basque Country) and urban (Barcelona and Turin) populations. The 
linkage between census data and death registries was achieved for almost 100% in all populations 
except Barcelona, Madrid and the Basque Country where the linkage was obtained for only 94.5%, 
70% and 94.1% of the population, respectively. To correct for the underestimation of deaths we 
weighted the number of deaths in the three Spanish populations with a correction factor. The 
correction factors were 1/0.945 for Barcelona, 1/0.7 for Madrid and 1/0.941 for the Basque Country. 
Data on determinants of mortality by socio-economic position came from nationally representative 
health or multipurpose surveys with a cross-sectional design (table 1).  
 
(Table 1 here) 
 
Measures 
The causes of death were classified according to the 9th and 10th revision of the International 
Classification of Diseases (ICD). We analysed a few large groups of causes [cardiovascular diseases 
(CVD), cancer, infectious diseases, respiratory diseases, alcohol-related causes, external causes and all 
other causes], as well as a few specific causes of death [ischemic heart disease (IHD), cerebrovascular 
disease, stomach cancer, lung cancer, breast cancer and pneumonia] (see supplementary table 1 for 
ICD-codes).  
Data on determinants included smoking, obesity, sedentary lifestyle and health services utilization. 
Smoking status was measured as self-reported current tobacco smoking. Obesity was measured on the 
basis of self-reported height and weight, and defined as a body mass index >29 and <70. Sedentary 
lifestyle was measured either by asking the best described respondents’ leisure time activities or the 
frequency of respondents’ physical exercises or activities. The measurement of health services 
utilization was based on visits to a general practitioner, to specialists, and to any physician. All 
analyses of health services utilization were adjusted for self-assessed health.  
Educational level declared at the census and during the interview surveys was used as a measure of 
socio-economic status and classified according to the International Standard Classification of 
Education (ISCED) using three categories: low (primary and lower secondary education), middle 
(upper secondary education) and high (post-secondary or tertiary education). Persons with missing 
information on educational level (generally <5%) were excluded from the analysis. 
 
 
 5 
Statistical analysis 
Analyses were conducted separately for men and women aged 30–74 years at baseline (i.e. at the time 
of census). The follow-up time was 10 years for most countries except Belgium, Denmark, Basque 
Country (5 years) and Madrid (1.5 years). To obtain comparable ages at death, analyses were 
conducted on slightly older age groups at baseline for countries with shorter follow-up period (35–79 
years for Madrid, and 30–79 years for Belgium and the Basque Country). In Denmark, no information 
on socio-economic status was available for subject aged >75 years. Further information on this 
adjustment procedure can be found elsewhere (13). 
Mortality rates by educational attainment were age-standardized with the direct method using the 
European Standard Population. The contribution of a specific cause of death to inequalities in all-
cause mortality between low- and high-educated people was determined as the share of the rate 
difference for each cause of death out of the rate difference for total mortality. The magnitude of 
mortality inequalities according to educational level was summarized by relative (relative index of 
inequality, RII) (14) as well as absolute (slope index of inequality, SII) measures of inequality (1) 
using Poisson regression due to count data.  
Prevalence rates of determinants by educational level were also age-standardized, and inequalities 
in determinant prevalence were summarized by RIIs. As the prevalence of the determinants was 
relatively high (>10%), we used log-binomial regression.  
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RESULTS 
Mortality analyses 
All populations included in the analysis show a graded relationship between education and mortality, 
but the absolute gap in mortality between the lowest and highest educated is smaller in the three 
Spanish populations (supplementary figure 1). Average mortality rates are also lower in Spain than in 
other Western European populations, both among men (with the exception of Barcelona) and 
particularly among women, where mortality in the lowest educated group is lower compared with the 
highest educated group in all other Western European populations.  
Table 2 shows relative inequalities in total and cause-specific mortality. Among men, relative 
inequalities in total mortality in all Spanish regions tend to be smaller than those in most other 
populations, although the differences are neither entirely consistent nor substantial. Among women, 
relative inequalities in total mortality in the three Spanish regions are substantially smaller than those 
in all other populations, with the exception of Turin, which has similarly small RIIs.  
Among men, relative inequalities in CVD mortality in the three Spanish regions are smaller than 
those in all other populations, but inequalities in mortality from other causes of death are similar in 
magnitude, or even larger than those elsewhere. Among women, relative inequalities in mortality from 
cancer are smaller in the three Spanish regions, but inequalities in mortality from other causes are not 
consistently smaller than those in other populations.  
Moreover, reverse pattern was observed for lung cancer among women in the three Spanish 
populations and Turin, and for breast cancer among women in all populations except Turin and the 
Basque Country. The large inequalities in mortality from infectious diseases in Spain are 
predominantly due to AIDS mortality. More detailed data on cause-specific mortality by educational 
level can be found in supplementary tables 2-4.  
 
(Table 2 here) 
 
Figure 1 quantifies the contribution of specific causes of death to the difference in age-standardized 
mortality rates between low and high educated men and women. It shows that the smaller absolute 
inequalities in mortality in the three Spanish populations are partly due to smaller absolute inequalities 
in CVD mortality. These are negligible in Spain, but substantial in most other populations. Among 
men, these smaller contributions of CVD are due to both lower average rates of mortality, and smaller 
relative inequalities in mortality (table 2). Among women, these smaller contributions of CVD are 
mainly due to lower average rates of mortality, and not to smaller relative inequalities in mortality. 
Among women, smaller or negative absolute inequalities in cancer mortality also contribute 
importantly to smaller absolute inequalities in mortality in Spain (see supplementary table 5). 
 
(Figure 1 here) 
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Analyses of survey data 
Among men, inequalities in smoking are smaller in Spain than in most other populations (figure 2) 
because of comparatively prevalent smoking among higher educated Spanish men (P-value < 0.0001 
for the comparison between Spanish men and the rest of the countries), while among women, they are 
small or absent in Spain because higher educated Spanish women smoke more than the lower 
educated.  
Similarly, the smaller inequalities in sedentary lifestyle in the Basque Country are due to the fact 
that the higher educated are less physically active (P-value < 0.0001). With regard to obesity, the 
inequalities are substantial in all countries (figure 2).  
After adjustment for self-assessed health, inequalities in health services utilization tended to favour 
the lower educated regarding visits to GP in most populations, including Spain. The opposite was 
observed for the use of specialized services, with the exception of the Basque Country. 
 
(Figure 2 here) 
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DISCUSSION 
Summary of findings 
The Spanish populations have considerably smaller absolute inequalities in total mortality than other 
Western European populations. This is the result of both lower average levels of mortality and smaller 
relative inequalities in mortality. However, the analysis by cause of death reveals an important 
heterogeneity: smaller relative inequalities in total mortality in Spain are due mainly to comparatively 
small inequalities in mortality from CVD (men) and cancer (women). Inequalities in mortality from 
most other causes are not smaller in Spain than elsewhere, and inequalities in infectious disease 
mortality are even substantially larger.  
Spain also has smaller inequalities in smoking and sedentary lifestyle, but not in health services 
utilization and its inequalities in obesity among women are larger than in the other populations. On the 
basis of these four determinants, one cannot therefore conclude that the exposure of lower socio-
economic groups to health risks is generally more favourable in Spain than elsewhere.  
 
Limitations 
Although education as a measure of socio-economic position remains constant during adult life and 
old age (15, 16), reverse causation is less likely (17) and educational level is comparable across 
European countries when broader categories classified according to the ISCED are used (18), the 
impact of education on individual overall socio-economic position may differ between countries.  
The comparability of the mortality rates may be compromised by differences between countries in 
calendar year at start and duration of follow-up. While we adjusted our results for different follow-up 
periods, we could not correct them for different starting years. Since there were mostly earlier for 
Northern Europe, and since inequalities in mortality have been widening in these European countries 
(19), any bias due to differences in starting year would tend to lead any differences in the magnitude of 
mortality inequalities in Spain to be underestimated. Regarding the differences in length of follow-up, 
‘sensitivity analysis’ (comparison of countries with similar length of follow-up) gives the same results. 
The data available on the prevalence of determinants and the mortality follow-up applied to the same 
period. Data that would allow proper time-lag to be incorporated between exposure and outcome in 
our analysis were not available. However, it is unlikely that the social patterning of these risk factors 
changes substantially within a 5- or 10-year period.  
We cannot exclude that some of our cause-specific results are affected by inaccuracies such as 
differences in certification or coding of causes of death between countries and socio-economic groups 
(20). However, we believe that those results using broad cause-of-death categories are likely to be 
robust.   
Differences in the magnitude of inequalities in mortality between Northern and Southern European 
populations may be biased by the fact that we compared national mortality data for Northern European 
countries with urban or regional mortality data in Southern European countries. Although Turin, 
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Barcelona, Madrid and the Basque Country are relatively more prosperous than other regions in Italy 
and Spain, results show that inequalities in mortality in Turin, Barcelona and Madrid (where the share 
of the urban population is very large) are not greater than in the Basque Country (which contains only 
three medium-sized cities). In addition, on the basis of national mortality data during the 1980s, Kunst 
et al. (21) have shown smaller inequalities in mortality in Italy and Spain as a whole. Recently, 
Regidor et al. (22) reported small inequalities in mortality among older people in Spain. We therefore 
think that the comparatively small inequalities in mortality observed in Barcelona, Madrid and the 
Basque Country can be generalized to Spain as a whole.  
 
Interpretation 
The smaller educational inequalities in mortality observed in Spain are likely to be an effect of a later 
socio-economic modernization of Spain than that of Northern Europe. The socio-economic 
modernization refers to the historical process of large-scale socio-economic changes in society, such 
as rising prosperity, industrialization, urbanization and expansion of mass education. This may have 
led to smaller educational inequalities in mortality in two ways.  
The first is that, due to later socio-economic modernization, educational attainment still may be less 
important as a social stratifier in Spain than in Northern Europe. During the 1990s, the proportion of 
low educated people was still about 70% in Spain, against only 30–50% in Northern Europe 
(supplementary table 6). Spain’s very rapid economic development after the Franco dictatorship (23) 
may have created a mismatch between education and other status-attainment variables such as income 
and occupational class. This is confirmed by a review of comparative studies which found weaker 
relationship between educational attainment and occupational class in Spain compared to Northern 
European countries (24, 25) and the Netherlands (26). The health survey data also suggested a weaker 
relationship between educational level and income in the Basque Country than in several Northern 
European countries, particularly among men (supplementary table 7).  
The second possible pathway is that later socio-economic development has delayed the 
epidemiologic transition (27). The transition from a mortality regime dominated by infectious diseases 
to one dominated by CVD and cancer occurred several decades later in Spain than in Northern Europe 
(28). The small absolute inequalities in CVD mortality in Spain are partly because average rates of 
mortality from CVD, particularly IHD, have remained low, especially among men (supplementary 
tables 2-4). While the increase in IHD mortality started many years later than in Northern Europe, the 
decline started only a few years later (29). The decline in IHD mortality in Spain after 1975 has been 
ascribed to the decline in smoking (only among men) and to improvements in medical care (e.g. 
cardiovascular drugs and intensive care units) (29). In other words, Spain already started to benefit 
from advances in knowledge about risk factors for IHD and advances in medical care before the 
epidemic could reach a higher peak.  
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That IHD mortality has never reached great heights in Spain is probably also due to the role of the 
Mediterranean diet with comparatively high consumption of wine, fish, fruits, vegetables, and olive oil 
(30). In view of the fact that partial adherence to the Mediterranean diet seems to explain the low 
average rates of mortality from IHD in Spain, it seems likely that adherence to this diet by lower 
socio-economic groups also explains part of the smaller inequalities in IHD mortality and the low rates 
of IHD mortality among the highe educated despite their high prevalence of smoking and physical 
inactivity. This is confirmed by a review of inequalities in diet in different European countries, which 
shows that the association between education and fruit and vegetables consumption is inconsistent in 
Spain (and clearly positive in Northern Europe), while the higher educated in Spain consume more 
animal fat and fewer vegetable oils than the lower educated (31). Not all studies, however, reach the 
same conclusions (32, 33).  
Another reason for the smaller relative inequalities in IHD mortality in Spain can probably also be 
found in the different timing of epidemiologic developments. Previous studies have concluded that 
Southern European countries tend to be at an earlier stage of the smoking epidemic, in which smoking 
is still more prevalent in upper socio-economic groups, especially among older people and women 
(19).  
Regarding cancer mortality, smaller absolute inequalities among women in the three Spanish 
populations were due partly to the strong reverse gradients for breast and lung cancer. Breast cancer is 
related to reproductive behaviour (a particularly high age at first pregnancy), and reverse gradients of 
breast cancer arise because higher educated women are the first to delay pregnancy to higher ages 
(34). The stronger reverse gradient in Spain may be due to the fact that this aspect of modernization 
started later, too (34).  
Spain had very large inequalities in mortality from infectious diseases, due mainly to AIDS.  
During the 1990s, large inequalities in AIDS mortality in Spain were driven by a combination of lower 
access and adherence to treatment and to unfavourable material conditions among vulnerable groups 
(35). The introduction of highly active antiretroviral therapy (HAART) has contributed importantly to 
narrowing absolute inequalities in AIDS mortality in Spain (36).  
 
Conclusion 
Educational inequalities in cause-specific mortality and its determinants are not consistently smaller in 
Spain than in other Western European populations. Smaller absolute inequalities in total mortality in 
Spain reflect smaller absolute inequalities in mortality from CVD and cancer. On the other hand, 
Spain does not have smaller inequalities in mortality from many other causes of death, and as many of 
these relate to living conditions, our findings suggest that smaller inequalities in total mortality in 
Spain do not reflect a generally more favourable situation with regard to social inequality. 
 Smaller inequalities in mortality from CVD and cancer are likely to be due to Spain’s later socio-
economic modernization. While the Spanish example shows that inequalities in total mortality are not 
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inevitable, the favourable situation in terms of inequalities in mortality from CVD and cancer in this 
country seems to be a historical coincidence rather than the outcome of deliberate policies. 
Unfortunately, in view of the on-going changes in social-protection policies in Spain and the changing 
socio-economic distribution of risk factors for mortality in the Spanish population (37), this favourable 
situation is also likely to be transitory.  
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Key points:  
• Although the social inequalities in mortality and health are relatively small in southern 
European countries compared to the rest of Europe, the smaller size of inequality in total 
mortality in Spain does not represent an unambiguously favourable situation. 
• Smaller inequalities in mortality in Spain were only found for cardiovascular disease and 
cancer. Inequalities in mortality from most other causes were not smaller in Spain than 
elsewhere.  
• The smaller inequalities for cardiovascular diseases and cancer did not resulted from lower 
risk factor prevalence in lower socio-economic groups but from relatively high risk factor 
prevalence in higher socio-economic groups.  
• The on-going changes in social-protection policies in Spain and the changing socio-economic 
distribution of risk factors for mortality in the Spanish population need to be taken into 
account to tackle health inequalities.  
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Table 1: Data sources of mortality and determininants, 30–74 years 
 
Country 
Mortality data Morbidity data 
Type of study Follow-up period 
Number of 
person years 
at risk 
Number of 
deaths Survey Years 
Number of 
respondents 
Finland National, longitudinal, census-
linked mortality study 
1990–2000 25874201 270130 Finbalt Health Monitor 1994, 1998, 
2000, 2002, 
2004 
15207 
Sweden National, longitudinal, census-
linked mortality study 
1991–2000 43042216 393038 Swedish Survey of Living Conditions 2000–2001 7999 
Norway National, longitudinal, census-
linked mortality study 
1990–2000 19956768 213022 Norwegian Survey of Living Conditions 2002 4834 
Denmark National, longitudinal, census-
linked mortality study 
1996–2000 13926291 136065 Danish Health and Morbidity Survey 2000 11739 
Belgium National, longitudinal, census-
linked mortality study 
1991–1995 24861015 283349 Health Interview Survey 1997–2001 13114 
Italy Urban, longitudinal, census-linked 
mortality study for the city of 
Turin 
 
1991–2001 4873109 50621 Health and Health Care Utilization, 
Multipurpose Family Survey, Aspects of 
Daily Living 
1999–2000, 
2000 
116600 
Spain Urban, longitudinal, census-linked 
mortality study for the city of 
Barcelona 
 
1992–2001 8151810 77101 National Health Survey 2001 13926 
 Regional, longitudinal, census-
linked mortality study for the 
region of Madrid 
 
1996–1997 3663333 22585    
 Regional, longitudinal, census-
linked mortality study for the 
Basque Country 
1996–2001 6098485 41704 Health Survey of the Basque Country 2002 8920 
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Table 2: Relative index of inequality (RII) for selected causes of death by educational level, and corresponding 95% confidence intervals (CI), nine European 
populations, 30–74 years 
 
 Finland Sweden Norway Denmark Belgium Turin Barcelona Madrid Basque country 
 RII 95%-CI RII 95%-CI RII 95%-CI RII 95%-CI RII 95%-CI RII 95%-CI RII 95%-CI RII 95%-CI RII 95%-CI 
Men                    
Cardiovascular diseases 2.17 (2.10-2.25) 1.99 (1.94-2.04) 2.12 (2.05-2.19) 1.81 (1.72-1.90) 1.77 (1.70-1.85) 1.51 (1.37-1.67) 1.29 (1.19-1.39) 1.20 (1.03-1.39) 1.25 (1.11-1.41) 
Ischemic heart disease 2.26 (2.17-2.36) 2.16 (2.09-2.23) 2.26 (2.17-2.36) 2.01 (1.88-2.16) 1.75 (1.64-1.86) 1.54 (1.31-1.80) 1.21 (1.08-1.36) 1.03 (0.83-1.28) 1.19 (1.00-1.43) 
Cerebrovascular disease 1.91 (1.76-2.06) 1.73 (1.63-1.84) 1.82 (1.68-1.97) 1.59 (1.42-1.78) 1.71 (1.55-1.89) 1.85 (1.49-2.30) 1.65 (1.39-1.96) 1.20 (0.85-1.68) 1.09 (0.85-1.39) 
Other circulatory diseases 2.11 (1.93-2.31) 1.75 (1.66-1.85) 1.97 (1.83-2.12) 1.59 (1.45-1.75) 1.83 (1.70-1.97) 1.31 (1.11-1.55) 1.18 (1.03-1.36) 1.43 (1.12-1.82) 1.46 (1.18-1.81) 
Cancer 1.68 (1.61-1.75) 1.32 (1.28-1.36) 1.46 (1.40-1.52) 1.32 (1.26-1.39) 1.81 (1.74-1.88) 1.86 (1.70-2.05) 1.55 (1.45-1.65) 1.52 (1.35-1.72) 1.57 (1.42-1.73) 
Stomach cancer 2.25 (1.89-2.69) 1.83 (1.61-2.09) 1.90 (1.62-2.22) 2.06 (1.56-2.72) 3.20 (2.57-3.97) 4.47 (2.80-7.16) 4.07 (2.91-5.69) 2.35 (1.44-3.85) 3.98 (2.58-6.14) 
Lung cancer 3.35 (3.07-3.65) 1.82 (1.70-1.94) 2.51 (2.31-2.73) 1.82 (1.66-1.99) 3.13 (2.92-3.36) 2.50 (2.12-2.96) 1.78 (1.58-2.01) 1.53 (1.22-1.90) 1.60 (1.33-1.93) 
Other cancer 1.22 (1.16-1.28) 1.19 (1.15-1.23) 1.20 (1.14-1.25) 1.14 (1.08-1.21) 1.25 (1.19-1.32) 1.50 (1.33-1.68) 1.36 (1.25-1.47) 1.45 (1.25-1.69) 1.43 (1.27-1.61) 
Infectious diseases 1.81 (1.41-2.32) 1.74 (1.45-2.10) 1.57 (1.22-2.01) 3.44 (2.54-4.66) 1.29 (1.05-1.58) 3.15 (1.30-7.59) 3.87 (3.09-4.85) 5.65 (3.64-8.77) 8.94 (6.24-12.80) 
Respiratory diseases 4.12 (3.72-4.57) 2.48 (2.29-2.68) 2.99 (2.73-3.27) 3.40 (3.02-3.81) 4.41 (3.97-4.89) 2.85 (2.07-3.91) 3.59 (2.93-4.39) 3.81 (2.63-5.53) 2.57 (1.87-3.53) 
Pneumonia 3.73 (3.24-4.30) 2.42 (2.12-2.75) 2.33 (2.00-2.71) 2.54 (1.90-3.37) 3.04 (2.48-3.74) 1.66 (0.93-2.97) 1.76 (1.18-2.62) 2.98 (1.54-5.79) 1.46 (0.72-2.99) 
Other respiratory diseases 4.57 (3.94-5.31) 2.51 (2.27-2.78) 3.41 (3.05-3.82) 3.59 (3.16-4.08) 4.94 (4.38-5.57) 3.49 (2.39-5.10) 4.45 (3.52-5.64) 4.24 (2.70-6.65) 2.90 (2.04-4.13) 
Alcohol-related causes 3.10 (2.85-3.38) 3.90 (3.51-4.33) 3.89 (3.37-4.48) 2.37 (2.10-2.68) 2.39 (1.98-2.87) 6.03 (2.71-13.40) 4.25 (2.36-7.68) 3.47 (1.27-9.45) 5.82 (2.90-11.67) 
External causes 2.69 (2.53-2.86) 2.01 (1.89-2.14) 2.54 (2.32-2.79) 3.25 (2.92-3.63) 2.15 (1.98-2.34) 1.60 (1.23-2.09) 2.28 (1.82-2.86) 1.88 (1.27-2.78) 3.60 (2.87-4.52) 
Other causes 1.94 (1.80-2.09) 1.85 (1.76-1.94) 2.06 (1.93-2.19) 2.34 (2.18-2.50) 2.06 (1.93-2.19) 1.94 (1.72-2.18) 2.00 (1.80-2.24) 1.87 (1.53-2.29) 1.73 (1.46-2.05) 
Total mortality 2.20 (2.15-2.25) 1.79 (1.76-1.81) 1.96 (1.92-2.00) 1.87 (1.82-1.93) 1.97 (1.92-2.02) 1.80 (1.70-1.90) 1.70 (1.62-1.77) 1.65 (1.52-1.79) 1.77 (1.66-1.89) 
                    
Women                   
Cardiovascular diseases 2.41 (2.29-2.54) 2.47 (2.38-2.57) 2.56 (2.44-2.69) 2.71 (2.50-2.95) 2.56 (2.39-2.74) 1.81 (1.52-2.14) 2.02 (1.73-2.35) 2.42 (1.77-3.30) 2.14 (1.61-2.84) 
Ischemic heart disease 2.75 (2.56-2.96) 2.79 (2.64-2.96) 3.04 (2.82-3.27) 3.50 (3.07-3.99) 3.11 (2.75-3.51) 1.99 (1.43-2.78) 2.31 (1.73-3.09) 2.13 (1.19-3.83) 2.35 (1.35-4.11) 
Cerebrovascular disease 2.08 (1.89-2.28) 2.06 (1.91-2.22) 2.02 (1.84-2.22) 2.11 (1.81-2.46) 2.05 (1.82-2.32) 1.42 (1.06-1.90) 1.67 (1.28-2.18) 2.36 (1.33-4.19) 2.20 (1.35-3.59) 
Other circulatory diseases 2.08 (1.84-2.35) 2.36 (2.18-2.56) 2.42 (2.19-2.68) 2.43 (2.09-2.83) 2.56 (2.31-2.85) 2.08 (1.57-2.74) 2.13 (1.67-2.73) 2.66 (1.65-4.29) 1.95 (1.24-3.07) 
Cancer 1.21 (1.15-1.27) 1.33 (1.28-1.37) 1.40 (1.34-1.47) 1.35 (1.28-1.42) 1.17 (1.10-1.23) 1.12 (0.99-1.27) 1.03 (0.93-1.15) 0.90 (0.74-1.09) 0.90 (0.76-1.06) 
Stomach cancer 1.42 (1.14-1.77) 1.88 (1.56-2.26) 1.77 (1.41-2.23) 1.53 (1.01-2.32) 2.41 (1.72-3.39) 3.17 (1.49-6.77) 1.95 (1.12-3.38) 2.27 (0.92-5.59) 1.79 (0.78-4.07) 
Lung cancer 1.87 (1.57-2.23) 1.86 (1.70-2.04) 2.93 (2.58-3.33) 2.42 (2.13-2.73) 1.63 (1.36-1.96) 0.74 (0.52-1.06) 0.48 (0.34-0.68) 0.34 (0.18-0.67) 0.33 (0.20-0.56) 
Breast cancer 0.84 (0.75-0.93) 0.87 (0.81-0.94) 0.77 (0.69-0.86) 0.83 (0.74-0.94) 0.82 (0.74-0.91) 0.94 (0.73-1.21) 0.78 (0.63-0.96) 0.51 (0.35-0.74) 0.91 (0.64-1.29) 
Other cancer 1.27 (1.19-1.35) 1.36 (1.31-1.42) 1.39 (1.31-1.47) 1.30 (1.20-1.39) 1.25 (1.17-1.34) 1.23 (1.04-1.45) 1.22 (1.07-1.40) 1.16 (0.90-1.49) 0.99 (0.80-1.22) 
Infectious diseases 1.93 (1.41-2.66) 2.16 (1.70-2.74) 2.04 (1.52-2.72) 3.10 (1.91-5.04) 2.12 (1.54-2.92) 2.40 (0.69-8.37) 5.31 (3.18-8.86) 2.90 (1.27-6.65) 4.63 (2.42-8.87) 
Respiratory diseases 3.06 (2.62-3.56) 2.61 (2.36-2.89) 3.00 (2.68-3.37) 3.51 (3.07-4.01) 3.05 (2.53-3.68) 1.95 (1.17-3.25) 1.40 (0.92-2.13) 2.85 (1.16-6.99) 1.59 (0.75-3.37) 
Pneumonia 3.17 (2.60-3.85) 2.95 (2.44-3.56) 2.14 (1.78-2.57) 2.88 (1.96-4.23) 2.87 (2.07-3.98) 1.15 (0.50-2.65) 1.21 (0.57-2.55) 2.81 (0.64-12.39) 2.42 (0.58-10.11) 
Other respiratory diseases 2.89 (2.26-3.69) 2.48 (2.20-2.80) 3.69 (3.19-4.28) 3.61 (3.13-4.16) 3.14 (2.50-3.94) 2.58 (1.34-4.96) 1.49 (0.90-2.48) 2.87 (0.93-8.87) 1.33 (0.56-3.20) 
Alcohol-related causes 3.82 (3.18-4.60) 3.79 (3.08-4.67) 3.39 (2.56-4.49) 2.20 (1.78-2.72) 1.66 (1.26-2.19) 6.34 (1.40-28.76) 3.36 (0.98-11.56) 1.49 (0.28-8.00) 4.39 (1.02-18.96) 
External causes 1.65 (1.48-1.84) 1.34 (1.22-1.47) 1.18 (1.02-1.37) 1.86 (1.58-2.18) 1.33 (1.18-1.52) 0.93 (0.63-1.38) 1.27 (0.88-1.83) 1.16 (0.58-2.34) 1.93 (1.19-3.13) 
Other causes 2.08 (1.91-2.26) 2.45 (2.30-2.62) 2.05 (1.89-2.21) 2.27 (2.06-2.49) 2.13 (1.96-2.32) 1.57 (1.32-1.85) 2.23 (1.87-2.65) 1.95 (1.37-2.76) 2.34 (1.70-3.20) 
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Total mortality 1.84 (1.78-1.89) 1.84 (1.80-1.88) 1.92 (1.87-1.98) 1.91 (1.84-1.99) 1.73 (1.67-1.79) 1.40 (1.29-1.52) 1.51 (1.40-1.62) 1.40 (1.22-1.61) 1.44 (1.28-1.63) 
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Figure  1: Contribution of causes of death to the difference in age-standardized mortality rates between low 
and high educated men and women, 30–74 years 
 
Legend: FIN = Finland, SWE = Sweden, NOR = Norway, DEN = Denmark, BEL = Belgium, TUR = Turin, BAR = 
Barcelona, MAD = Madrid, BSQ = Basque Country 
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*: Statistically significant RII values (p<0.05) 
 
Figure 2: Age-adjusted prevalence and relative index of inequality of (A) current smoking, (B) obesity, (C) sedentary lifestyle, (D) visit to GP and (E) visit to 
specialist 
Legend: FIN =Finland, SWE = Sweden, NOR = Norway, DEN = Denmark, BEL = Belgium, ITA = Italy, SPA = Spain, BSQ = Basque Country 
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Supplementary material 
 
 
 
 
Supplementary figure 1: Age-standardized mortality rates (per 100 000 person-years) according to the 
educational level, 30–74 years 
 
Legend: FIN = Finland, SWE = Sweden, NOR = Norway, DEN = Denmark, BEL = Belgium, TUR = Turin, BAR = 
Barcelona, MAD = Madrid, BSQ = Basque Country 
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Supplementary table 1: ICD codes of causes of death selected for the analysis 
 
Causes of death ICD-9 codes ICD-10 codes 
Cardiovascular 390–459 I00–I99 
IHD 410–414 I20–I25 
Cerebrovascular 430–438 I60–I69 
Other circulatory Rest (390–459) Rest (I00–I99) 
Cancer 140–239 C00–D48 
Stomach cancer 151 C16 
Lung cancer 162–163, 165 C33–C34, C39 
Breast cancer 174–175 C50 
Other cancer Rest (140–239) Rest (C00–D48) 
Infectious diseases 001–139 A00–B99 
Respiratory diseases 480–487, 490–494, 496 J10–J18, J40–J47 
Pneumonia 480–487 J10–J18 
Other 490–494, 496 J40–J47 
Alcohol-related causes 291,303,305.0,425.5, 571.0–
571.3, 577.0–577.1, E860 
F10, I42.6, K70, K85–K86.0, 
X45 
External causes E800–E999 (except E860) V01–Y98 (except X45) 
Other causes Rest (001–E999) Rest (A00–Y98) 
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Supplementary table 2: Age-standardized mortality rates (per 100 000), low education, 30–74 years 
 
 Finland Sweden Norway Denmark Belgium Turin Barcelona Madrid Basque  
Men          
Cardiovascular diseases 784.8 544.8 680.3 419.7 497.2 418.0 373.3 254.4 254.5 
Ischemic heart disease 537.5 346.5 427.8 232.9 214.0 169.4 166.3 105.7 108.5 
Cerebrovascular disease 139.5 88.1 114.2 76.2 98.2 100.1 89.3 48.7 58.7 
Other circulatory diseases 107.9 110.2 138.3 110.6 185.0 148.5 117.8 100.0 87.4 
Cancer 425.5 341.9 456.4 420.7 537.7 520.0 579.8 411.5 418.5 
Stomach cancer 29.3 18.8 30.1 14.3 24.6 30.3 33.5 29.0 32.5 
Lung cancer 144.0 72.5 126.6 129.4 221.1 182.3 181.4 121.8 111.0 
Other cancer 252.2 250.5 299.7 276.9 292.0 307.4 364.9 260.7 274.9 
Infectious diseases 12.1 9.1 11.8 14.1 16.8 6.8 63.2 41.7 40.6 
Respiratory diseases 123.5 56.1 104.5 101.6 132.6 58.5 91.7 70.8 55.8 
Pneumonia 59.8 20.9 33.4 15.2 29.1 13.7 17.5 19.1 8.1 
Other respiratory diseases 63.7 35.2 71.2 86.5 103.5 44.9 74.2 51.7 47.8 
Alcohol-related causes 97.2 38.3 48.8 71.7 23.2 10.5 10.3 7.3 11.9 
External causes 184.2 89.0 95.7 101.5 103.4 57.0 53.7 36.2 77.2 
Other causes 148.9 132.9 195.1 245.7 244.9 330.6 235.7 166.2 145.8 
Total mortality 1776.2 1212.3 1592.6 1374.9 1555.7 1401.5 1407.7 988.2 1004.3 
          
Women          
Cardiovascular diseases 329.8 239.7 295.9 201.6 262.0 197.4 155.1 107.3 96.4 
Ischemic heart disease 183.9 120.2 149.4 89.9 86.6 55.3 46.0 29.5 27.0 
Cerebrovascular disease 92.4 60.1 77.2 53.4 70.2 62.9 47.4 30.8 31.5 
Other circulatory diseases 53.4 59.5 69.4 58.2 105.2 79.3 61.8 47.1 37.9 
Cancer 248.2 271.0 316.4 352.2 262.1 267.0 230.6 164.1 164.8 
Stomach cancer 13.2 9.9 13.3 6.4 9.5 12.3 11.3 11.6 9.5 
Lung cancer 24.4 40.5 55.1 86.2 26.0 29.3 15.3 9.4 10.6 
Breast cancer 44.6 43.0 47.0 63.1 63.0 59.6 51.4 32.1 34.5 
Other cancer 165.9 177.6 201.1 196.5 163.5 165.8 152.6 110.8 110.2 
Infectious diseases 7.6 6.5 8.6 5.9 9.7 3.8 15.6 11.8 11.9 
Respiratory diseases 41.7 38.3 63.0 89.4 35.7 22.5 17.6 13.9 12.1 
Pneumonia 26.3 11.6 20.1 9.7 11.8 6.6 5.2 5.1 3.6 
Other respiratory diseases 15.5 26.7 43.0 79.8 23.9 15.9 12.5 8.8 8.5 
Alcohol-related causes 23.0 10.3 13.0 25.5 10.0 3.6 2.7 2.6 3.7 
External causes 53.5 34.8 30.7 42.0 43.8 24.2 18.5 12.5 19.4 
Other causes 117.6 92.2 116.0 150.0 148.2 182.3 123.2 76.7 78.0 
Total mortality 821.3 692.9 843.6 866.6 771.5 701.0 563.3 389.0 386.3 
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Supplementary table 3: Age-standardized mortality rates (per 100 000), middle education, 30–74 years 
 
 Finland Sweden Norway Denmark Belgium Turin Barcelona Madrid Basque  
Men          
Cardiovascular diseases 641.5 424.1 522.2 360.5 421.1 369.3 302.1 253.8 229.5 
Ischemic heart disease 437.8 259.8 321.0 193.3 183.8 152.8 139.9 111.7 102.9 
Cerebrovascular disease 118.4 73.4 92.9 68.0 85.6 81.8 61.7 46.9 48.9 
Other circulatory diseases 85.3 90.8 108.3 99.1 151.6 134.6 100.5 95.2 77.7 
Cancer 364.0 315.1 394.9 411.3 445.9 405.7 437.3 403.6 355.7 
Stomach cancer 22.1 15.8 22.4 11.1 15.1 17.4 14.7 23.5 15.7 
Lung cancer 103.4 61.6 90.1 119.1 148.5 124.3 134.3 118.0 88.7 
Other cancer 238.4 237.7 282.4 281.1 282.3 263.9 288.2 262.1 251.3 
Infectious diseases 11.9 7.3 9.3 7.5 15.1 4.0 37.5 19.5 19.9 
Respiratory diseases 82.4 42.0 70.0 70.9 78.5 37.7 48.1 48.0 39.3 
Pneumonia 41.4 15.0 23.4 10.0 20.0 8.8 11.3 12.5 6.1 
Other respiratory diseases 41.0 27.0 46.7 61.0 58.5 28.8 36.9 35.5 33.2 
Alcohol-related causes 78.1 26.0 31.7 59.7 18.7 5.1 4.3 6.8 6.1 
External causes 148.9 71.8 66.9 65.0 80.0 49.1 37.3 25.7 50.5 
Other causes 132.5 106.5 148.6 182.5 188.5 251.5 163.8 140.6 124.4 
Total mortality 1459.3 992.7 1243.5 1157.4 1247.7 1122.3 1030.4 898.0 825.4 
          
Women          
Cardiovascular diseases 242.2 174.5 201.4 139.1 175.1 154.7 98.3 71.9 68.7 
Ischemic heart disease 131.8 84.3 94.2 56.3 50.4 41.3 27.3 26.8 21.4 
Cerebrovascular disease 70.3 47.2 58.2 41.0 52.9 54.2 30.1 17.7 25.5 
Other circulatory diseases 40.1 42.9 48.9 41.8 71.8 59.1 40.9 27.4 21.9 
Cancer 229.2 246.9 268.7 317.4 246.3 257.4 193.7 186.5 178.6 
Stomach cancer 12.2 7.6 9.6 5.7 6.0 6.4 4.7 6.3 9.5 
Lung cancer 18.6 35.1 35.1 65.5 22.6 33.4 22.8 18.8 16.2 
Breast cancer 44.9 44.2 50.0 66.5 70.0 63.2 45.4 43.2 37.4 
Other cancer 153.4 160.0 173.9 179.8 147.7 154.5 120.9 118.1 115.5 
Infectious diseases 6.5 4.6 6.4 4.1 6.3 3.2 9.7 9.3 6.6 
Respiratory diseases 28.9 27.6 38.4 60.1 22.6 17.4 13.6 10.0 13.5 
Pneumonia 17.7 7.1 13.7 6.2 6.5 6.3 5.2 3.6 3.7 
Other respiratory diseases 11.2 20.5 24.7 53.9 16.2 11.1 8.4 6.3 9.8 
Alcohol-related causes 14.0 7.0 8.4 21.8 9.1 1.9 0.8 3.1 3.1 
External causes 45.7 31.0 26.7 29.2 36.4 22.7 17.7 9.9 14.3 
Other causes 87.6 64.9 86.7 107.6 107.5 149.3 78.8 57.1 53.3 
Total mortality 654.0 556.5 636.8 679.3 603.4 606.7 412.7 347.7 338.0 
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Supplementary table 4: Age-standardized mortality rates (per 100 000), high education, 30–74 years 
 
 Finland Sweden Norway Denmark Belgium Turin Barcelona Madrid Basque  
Men          
Cardiovascular diseases 472.0 313.2 368.8 253.9 340.6 310.0 346.0 227.4 228.7 
Ischemic heart disease 310.4 188.3 220.9 129.0 147.8 120.9 158.1 101.1 97.9 
Cerebrovascular disease 92.1 55.5 68.8 51.1 67.1 63.4 73.6 43.0 61.7 
Other circulatory diseases 69.5 69.4 79.2 73.8 125.7 125.6 114.3 83.3 69.1 
Cancer 306.9 267.8 338.9 319.2 363.4 349.3 481.0 298.5 319.4 
Stomach cancer 17.5 11.0 19.6 8.6 12.1 9.9 17.4 16.4 14.9 
Lung cancer 63.2 41.4 61.3 70.6 104.2 101.1 137.1 89.4 84.3 
Other cancer 226.2 215.5 258.0 240.0 247.1 238.3 326.5 192.8 220.2 
Infectious diseases 8.1 5.7 8.1 7.1 13.8 3.7 32.0 19.4 13.7 
Respiratory diseases 48.3 24.9 44.1 34.7 51.5 32.1 49.7 29.7 31.1 
Pneumonia 25.8 10.4 18.4 8.6 14.3 13.4 15.1 10.2 7.2 
Other respiratory diseases 22.4 14.5 25.7 26.1 37.2 18.7 34.6 19.5 23.9 
Alcohol-related causes 41.3 10.7 16.6 34.6 12.7 3.6 5.3 2.5 4.0 
External causes 92.3 50.0 48.7 46.6 63.4 38.9 35.7 27.2 36.8 
Other causes 102.2 80.3 111.8 132.3 159.6 229.2 171.8 115.9 109.8 
Total mortality 1071.0 752.6 936.9 828.4 1005.0 966.8 1121.6 720.6 743.5 
          
Women          
Cardiovascular diseases 183.5 114.8 135.9 102.7 153.7 134.4 121.6 65.9 61.4 
Ischemic heart disease 90.4 51.0 62.1 38.1 48.7 35.2 33.7 14.3 15.3 
Cerebrovascular disease 57.9 32.6 43.1 32.1 45.5 52.2 42.2 22.7 15.8 
Other circulatory diseases 35.2 31.2 30.6 32.5 59.5 47.0 45.7 28.9 30.4 
Cancer 224.1 214.9 247.0 287.3 242.6 236.5 250.3 157.1 170.7 
Stomach cancer 9.8 6.3 9.8 4.7 6.0 7.3 10.7 9.2 4.2 
Lung cancer 17.3 21.9 23.1 45.4 19.0 35.2 23.0 13.1 21.6 
Breast cancer 53.1 48.4 58.7 71.6 70.9 56.5 64.9 48.7 36.3 
Other cancer 143.9 138.3 155.4 165.7 146.7 137.5 151.7 86.1 108.6 
Infectious diseases 4.3 3.8 4.3 2.6 7.2 0.4 7.2 6.4 6.9 
Respiratory diseases 20.5 17.1 26.3 33.0 19.1 12.7 16.4 7.3 7.1 
Pneumonia 13.3 6.0 12.9 5.5 7.7 6.4 4.4 3.4 1.8 
Other respiratory diseases 7.2 11.1 12.4 27.4 11.5 6.3 11.9 3.9 5.3 
Alcohol-related causes 11.3 3.6 4.6 14.4 7.2 1.2 2.6 0.6 1.7 
External causes 41.2 26.9 27.2 32.6 40.2 25.3 15.7 11.9 11.4 
Other causes 79.7 47.5 64.5 92.0 97.7 138.9 87.7 59.3 54.5 
Total mortality 564.7 428.5 509.6 564.6 567.7 549.4 501.5 308.4 313.8 
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Supplementary table 5: Slope index of inequality according to cause of death (per 100 000), nine European 
populations, average age at death 30–74 years 
 
 Finland Sweden Norway Denmark Belgium Turin Barcelona Madrid Basque 
Men          
Cardiovascular diseases 525.5 313.5 402.3 213.2 260.2 162.6 89.5 44.7 54.5 
Ischemic heart disease 375.6 217.5 269.0 135.6 109.4 68.5 30.7 3.0 18.6 
Cerebrovascular disease 80.1 42.5 57.1 31.5 48.9 56.1 40.8 8.5 4.9 
Other circulatory diseases 69.7 53.5 76.1 45.8 102.0 38.7 18.7 33.5 31.5 
Cancer 201.1 88.2 152.8 111.1 289.9 293.5 234.4 162.7 177.3 
Stomach cancer 20.2 9.9 15.4 8.5 23.0 33.7 34.6 21.3 35.3 
Lung cancer 135.4 37.3 85.3 66.8 203.4 142.6 94.3 48.6 49.2 
Other cancer 48.2 41.3 50.8 35.9 64.3 116.7 105.1 92.6 93.6 
Infectious diseases 6.3 4.3 4.4 11.0 4.1 6.3 57.5 44.9 45.5 
Respiratory diseases 129.2 40.2 81.2 87.6 147.7 50.8 90.7 73.9 46.1 
Pneumonia 59.1 14.5 21.7 10.5 26.6 6.3 8.8 17.1 2.9 
Other respiratory diseases 70.3 25.8 59.2 77.1 120.5 44.6 81.7 57.0 43.5 
Alcohol-related causes 80.3 33.3 38.8 48.0 16.7 12.2 10.2 7.0 14.1 
External causes 140.6 50.5 62.1 79.7 67.1 24.6 35.5 19.9 71.1 
Other causes 86.0 68.2 109.4 161.0 156.2 194.7 143.4 94.0 73.4 
Total mortality 1191.3 602.3 859.3 726.3 942.0 746.5 670.2 456.1 524.2 
          
Women          
Cardiovascular diseases 248.5 174.8 214.9 161.1 215.7 109.2 100.1 85.3 67.9 
Ischemic heart disease 155.9 96.6 121.1 84.6 82.6 35.2 34.8 20.6 21.1 
Cerebrovascular disease 59.5 36.6 45.0 34.0 46.0 21.3 23.0 23.8 22.9 
Other circulatory diseases 34.0 41.4 48.3 42.4 87.0 52.9 42.5 40.8 23.9 
Cancer 45.2 71.4 95.4 98.4 39.4 29.9 7.2 -18.1 -17.4 
Stomach cancer 4.4 5.2 6.4 2.5 7.4 11.9 7.0 8.5 5.3 
Lung cancer 13.5 21.2 41.1 61.8 11.8 -8.8 -11.6 -10.3 -11.7 
Breast cancer -7.9 -6.0 -13.0 -11.8 -12.4 -3.9 -12.9 -22.5 -3.2 
Other cancer 37.6 51.1 60.0 48.1 35.8 33.4 30.0 16.1 -1.5 
Infectious diseases 4.4 4.0 4.9 4.9 6.5 3.0 17.5 10.5 12.5 
Respiratory diseases 36.9 28.4 49.2 83.5 33.4 14.0 5.7 12.7 5.4 
Pneumonia 23.7 9.2 12.4 7.8 10.7 0.9 1.0 4.6 2.8 
Other respiratory diseases 13.2 19.1 36.9 75.8 22.7 13.4 4.8 8.1 2.4 
Alcohol-related causes 19.7 8.5 9.5 16.2 4.7 4.6 2.5 1.1 4.2 
External causes 22.9 8.9 4.7 21.3 12.0 -1.8 4.2 1.9 11.6 
Other causes 73.7 64.1 67.1 99.8 100.8 77.4 89.2 47.3 59.6 
Total mortality 443.7 362.5 456.0 484.4 394.9 228.0 221.1 127.1 137.2 
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Supplementary table 6: Educational distribution (in %), mortality data, 30–74 years 
 
Country  Educational level 
Lower secondary and less Upper secondary Tertiary 
Finland 50.1 29.3 20.6 
Sweden 40.6 41.7 17.7 
Norway 33.1 47.7 19.2 
Denmark 45.1 34.9 20.0 
Belgium 64.4 20.3 15.3 
Italy (Turin) 71.5 19.8   8.6 
Spain (Barcelona) 71.5 12.1 16.4 
Spain (Madrid) 70.4 14.8 14.9 
Spain (Basque) 70.9 16.2 12.9 
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Supplementary table 7: Prevalence ratios of being in the lowest income quintiles (4-5) by educational level in 
the population over 50 years 
 
Country Education 
Men Women 
Prevalence 
ratio 95%-CI 
Prevalence 
ratio 95%-CI 
Norway low 4.81 (3.57-6.47) 3.36 (2.65-4.25) 
  middle 2.77 (2.05-3.75) 2.04 (1.60-2.61) 
 high 1 - 1 - 
Sweden low 3.43 (2.74-4.29) 3.91 (3.19-4.79) 
  middle 1.80 (1.42-2.29) 2.24 (1.81-2.78) 
 high 1 - 1 - 
Denmark low 2.80 (2.50-3.14) 2.73 (2.47-3.02) 
  middle 1.93 (1.71-2.18) 1.77 (1.57-2.00) 
 high 1 - 1 - 
Belgium low 2.26 (1.98-2.58) 2.07 (1.80-2.38) 
  middle 1.48 (1.26-1.73) 1.46 (1.24-1.71) 
 high 1 - 1 - 
Basque Country low 2.06 (1.69-2.53) 2.34 (1.47-3.72) 
 middle 1.18 (0.89-1.56) 0.90 (0.41-1.99) 
 high 1 - 1 - 
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